IFIGENIA-study in IPF: effects of N-acetylcysteine (NAC) on CRP, dyspnea, exercise test and HRCT
M. Demedts, J. Behr, R. Buhl, U. Costabel, H. M. Jansen, M. Thomeer, B. Wallaert, I. Lankhorst, M. Sardina, G. Corvasce, M. Montanari, F. Laurent, J. Verschakelen, C. D. R. Flower (Leuven, Belgium)
Source: Annual Congress 2004 - Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Demedts, J. Behr, R. Buhl, U. Costabel, H. M. Jansen, M. Thomeer, B. Wallaert, I. Lankhorst, M. Sardina, G. Corvasce, M. Montanari, F. Laurent, J. Verschakelen, C. D. R. Flower (Leuven, Belgium). IFIGENIA-study in IPF: effects of N-acetylcysteine (NAC) on CRP, dyspnea, exercise test and HRCT. Eur Respir J 2004; 24: Suppl. 48, 4077
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
CT scan derived emphysema scores correlate with spirometry and gas exchange but not acute exacerbation rates (AER) or COPD assessment test (CAT) in COPD subjects with and without alpha-1-antitrypsin (AAT) deficiency Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
Combination of six-minute walk test (6MWT) and exhaled carbon monoxide (eCO) measurement in patients with exogenous allergic alveolitis (EAE) and idiopathic pulmonary fibrosis (IPF) – test of a new approach Source: Eur Respir J 2007; 30: Suppl. 51, 580s Year: 2007
The relationship between the lung function and dyspnea, cough, and exercise capacity in the not-treated COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 511s Year: 2005
The role of cardio pulmonary exercise testing (CPET) in patients with cystic fibrosis (CF) Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009
The effects of adding formoterol (F) and tiotropium (T) on exercise performance and breathlessness in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 577s Year: 2005
Correlation of dyspnea scores with pulmonary function, high-resolution computed tomography (HRCT) and exercise capacity in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 305s Year: 2006
The performance of COPD assessment test (CAT) in mustard lung patients Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012
The EDD (exercise, DLco, dyspnea) index in diffuse systemic sclerosis with pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Cardiopulmonary exercise test (CPET) may show initial left cardiac dysfunction in patients with moderate-severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
A six minute walking test (6MWT) derived index (O2-GAP) predicts mortality in IPF Source: International Congress 2015 – IPF: clinical aspects II Year: 2015
Comparative evaluation on the synergism of roflumilast (RFL) and glycopyrronium (Gly) vs ciclesonide (CLS) and Gly on lung volumes and exercise tolerance in severe COPD Source: International Congress 2015 – Clinical exercise physiology in health and disease Year: 2015
IFIGENIA (i diopathic pulmonary f ibrosis i nternational g roup e xploring N AC I a nnual): effects of N-acetylcysteine (NAC) on lung function and gas exchange in IPF pati Source: Eur Respir J 2004; 24: Suppl. 48, 668s Year: 2004
Salmeterol/fluticasone propionate (SFC) improves the inspiratory to total lung capacity ratio (IC/TLC) and exercise endurance time in patients with COPD Source: Annual Congress 2006 - COPD therapy Year: 2006
Effects of oxygen inhalation during exercise in patients with combined pulmonary fibrosis and emphysema (CPFE) Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010
Subjective (CAT, MMRC) versus objective (PFT, 6MWD, SPO2) assessment in stable COPD patients Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care Year: 2012
Correlation of induced sputum (IS) particles size distribution (PDS) and pulmonary function test (PFT) in asthmatics patients (A-pts) Source: Eur Respir J 2004; 24: Suppl. 48, 604s Year: 2004
Endurance shuttle walking test: responsiveness to salmeterol in COPD Source: Eur Respir J 2008; 31: 579-584 Year: 2008
COPD phenotypes by high resolution computed tomography (HRCT) and ventilatory response to exercise Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015
Four weeks of treatment with n-acetyl cysteine (NAC) (1200mg/day) reduces lung oxidative stress and improves lung function in moderate-to-severe COPD subjects Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Metronome-paced hyperventilation, CT measurements and exercise to investigate dynamic hyperinflation contrasting tiotropium versus indacaterol treatment in moderate COPD patients Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015